Search
Cypherpunk Launches Zcash Treasury With $50M Backing
13.11.2025
Gemini co-founder Tyler Winklevoss launches Cypherpunk to accumulate Zcash as a privacy-focused treasury asset. Tyler Winklevoss announced the launch of Cypherpunk, a company funded with over $50 million from Winklevoss Capital to accumulate Zcash (ZEC) as a privacy and self‑sovereignty treasury...
Leap Therapeutics Surges 300% on $50M Winklevoss-Backed Zcash Bet
12.11.2025
The company is also rebranding as Cypherpunk Technologies with ticker change to CYPH, effective Thursday
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token